U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07119372) titled 'Study of the Efficacy and Safety of BCD-131 and Mircera(R) in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis' on Aug. 07.

Brief Summary: BCD-131 is pegylated darbepoetin beta. This clinical study BCD-131-3 is a randomized, open-label, phase III study of the efficacy and safety of BCD-131 and Mircera used for the treatment of anemia in end-stage chronic kidney disease (CKD) patients on dialysis.

Study Start Date: March 01

Study Type: INTERVENTIONAL

Condition: Anemia Chronic Kidney Disease Chronic Kidney Disease Patients on Hemodialysis Chronic Kidney Disease 5D

Intervention: BIOLOGICAL: BCD-131 (peg...